The U.S. Senate heeded the recommendation of the Senate Labor and Human Resources Committee and voted to confirm Jane Henney, M.D., as the commissioner of the Food and Drug Administration.
WASHINGTON - The U.S. Senate heeded the recommendation of the Senate Labor and Human Resources Committee and voted to confirm Jane Henney, M.D., as the commissioner of the Food and Drug Administration.
"The discussions I have had with many members of the Senate over the past several weeks have reaffirmed my belief that the FDA serves as a non-partisan arbiter of public policy, with decisions that are grounded in science and law," Henney said.
"As I have made clear in prior statements, my priority as commissioner will be to implement the FDA Modernization Act and to strengthen the agency's scientific base to ensure the best science guides the critical decisions that need to be made," Henney said.
Secretary Shalala said of Henney: "Jane Henney is a seasoned professional who brings substantial management skills and a depth of experience to the agency. The FDA safeguards food and drugs from the factory to the store shelf to every medicine cabinet and kitchen cupboard in America. Dr. Henney has the judgment to carry out that vital responsibility in a changing health marketplace, and I know that she will forge new and productive relationships with consumers and the industry." PR
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
February 4th 2025Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.